Microban Helps Medical Manufacturers Address HAIs

Article

Microban International, a global leader in built-in antimicrobial product protection, announced today a new initiative designed to help medical device manufacturers get to market quicker with antimicrobial solutions for 510(k) registered medical devices used in hospitals and other healthcare facilities.

Helthcare-acquired infections (HAIs) are responsible for approximately 100,000 deaths per year and incur in excess of $20 billion in healthcare costs. "Our expertise utilizing a breadth of antimicrobial technologies enables us to help manufacturers of medical devices develop safer and more effective antimicrobial solutions for their products and provides an important resource to help address the growing concern over hospital acquired infections," said David Meyers, president and CEO of Microban International.

Microban has an extensive portfolio of organic, inorganic and organometallic antimicrobial technologies which enable it to choose the optimal technology for the device. It works closely with customers to engineer antimicrobial solutions that are designed to meet the specific needs of each unique device application, evaluating important criteria such as: antimicrobial performance utilizing industry standard protocols and testing for specific microorganisms and relevant kill times; durability requirements and exposure time periods; product usage environment; manufacturing parameters; and necessary regulatory approvals.

With more than 20 years of experience engineering antimicrobial solutions across a breadth of product applications and materials including expertise with thermoplastics, cross-linked thermosets, coatings and textiles Microban says it can help medical device manufacturers to more effectively and accurately screen and optimize potential antimicrobial technologies.  In addition, its onsite state-of-the-art microbiology laboratory utilizes a high throughput quantitative testing system that enables Microban to quickly and reliably deliver accurate data and proof of concept studies.

Microban offers full service support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance.  For more information, medical manufacturers should visit http://www.microban.com/microban-medical.

 

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content